Andrew P. Mazar
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
2014-01-01–2022-04-08
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Actuate Therapeutics, Inc. (ACTU) | Ph. D. Chief Operating Officer | $450,000 | $1,419,569 |
| 2024 | Actuate Therapeutics, Inc. (ACTU) | Ph. D. Chief Operating Officer | $450,000 | $675,000 |
| 2023 | Actuate Therapeutics, Inc. (ACTU) | Ph. D. Chief Operating Officer | $450,000 | $666,112 |
| 2020 | Monopar Therapeutics (MNPR) | Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | $438,008 | $872,571 |
| 2019 | Monopar Therapeutics (MNPR) | Ph.D., Executive Vice President of Research & Development, Chief Scientific Officer and Director | $360,500 | $465,500 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.